Emergent BioSolutions shares rose after the company disclosed that it will supply additional doses of CNJ-016, a treatment ...

About an hour after the closing bell, shares of Emergent were trading 6.4% higher, at $7.31. The company's shares ended the day's regular session at $6.87, a gain of 3.7%.

Emergent BioSolutions (EBS) has secured a $51.9M contract modification award to deliver CNJ-016 to the Administration for Strategic Preparedness and Response (A ...

In April of that year, patients started appearing at hospitals in the industrial city of Sverdlovsk, now known as ...

The suit addresses the scrapping of COVID-19 vaccination recommendations for children and pregnant women and the dismantling ...

A coalition of doctors’ groups and public health organizations sued the U.S. government on Monday over the decision to stop ...

Roughly 4,000-year-old bones from Chile contain genetic evidence of leprosy, suggesting that a rare form of the bacteria that causes the disease may have been circulating in the Americas and long ...

I’ve always admired medical wizards who, in dire circumstances like the recent COVID-19 epidemic, somehow come up with ...